Overactive Bladder
A comparison study of two lower urinary tract symptoms screening tools in clinical practice: The B-SAQ and OAB-V8 questionnaires - Abstract
January 4, 2013
Safety and tolerability of solifenacin add-on therapy to α-blocker treated men with residual urgency and frequency - Abstract
January 4, 2013
Treatments for overactive bladder: Focus on pharmacotherapy - Abstract
December 22, 2012
The vagina as a route for drug delivery: A review - Abstract
December 20, 2012
The effect of pelvic organ prolapse severity on improvement in overactive bladder symptoms after pelvic reconstructive surgery - Abstract
December 19, 2012
Anticholinergic drugs versus non-drug active therapies for non-neurogenic overactive bladder syndrome in adults - Abstract
December 18, 2012
Overactive bladder, differential diagnosis, and clinical utility of fesoterodine - Abstract
December 14, 2012
Validation of the Patient Global Impression scales for use in detrusor overactivity: Secondary analysis of the RELAX study - Abstract
December 13, 2012
Effect of renal or hepatic impairment on the pharmacokinetics of mirabegron - Abstract
December 13, 2012
Urological problems in Parkinson's disease: Clinical aspects - Abstract
December 13, 2012
Latest treatment for lower urinary tract dysfunction: Therapeutic agents and mechanism of action - Abstract
December 11, 2012